SYK vs BSX
SYK and BSX side by side — valuation & fundamentals (public data).
Key statistics
| Metric | SYKSTRYKER CORP | BSXBOSTON SCIENTIFIC CORPORATION |
|---|---|---|
| Market cap | $108.02B | $63.59B |
| P/E (TTM) | 29.2 | 17.8 |
| P/B | 9.21 | 2.55 |
| P/S | 4.3x | 3.2x |
| Dividend yield | 1.19% | — |
| Revenue | $25.84B(TTM) | $21.00B(TTM) |
| Revenue growth (YoY) | 11.2% | 19.9% |
| Net income | $3.73B(TTM) | $3.67B(TTM) |
| Earnings growth (YoY) | 8.5% | 56.7% |
| EPS, diluted | $9.65(TTM) | $2.47(TTM) |
| EBIT margin | 19.5% | 18.0% |
| ROE | 27.7% | 11.6% |
| ROIC | 15.1% | 10.0% |
| Piotroski F | 8/9 | 8/9 |
| 1y total return | -24.5% | -56.1% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: SYK vs BSX
| Metric | SYK | BSX |
|---|---|---|
| End value | $28.1K | $19.9K |
| Total return | +181.4% | +99.0% |
| CAGR | +10.5% | +6.9% |
| Volatility | 26.7% | 27.4% |
| Sharpe | 0.36 | 0.23 |
| Sortino | 0.51 | 0.31 |
| Max drawdown | -43.8% | -60.6% |
Based on 2600 common trading days, 2016-05-12 → 2026-09-15 · risk-free 4.11% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)